Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (241-250 of 505) with videos related to

Pageof 51
Sort By:
Respiratory Medicine|April 7, 2020
Goals of COPD treatment: Focus on symptoms and exacerbationsClaus F Vogelmeier, Miguel Román-Rodríguez, Dave Singh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2017
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromideDave Singh, Massimo Corradi, Monica Spinola, et al.
British Journal of Clinical Pharmacology|June 3, 2020
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppressionPeter Daley-Yates, Noushin Brealey, Sebin Thomas, et al.
International Immunopharmacology|October 29, 2011
Reduced glucocorticoid receptor expression and function in airway neutrophilsJonathan Plumb, Kate Gaffey, Binita Kane, et al.
Plos One|November 9, 2020
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine studyHilary Siddall, Diana Quint, Hitesh Pandya, et al.
Therapeutic Advances in Respiratory Disease|August 25, 2021
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler <i>versus</i> dual therapies in patients with COPD: a sub-study of the ETHOS trialKlaus F Rabe, Fernando J Martinez, Dave Singh, et al.
Transplantation|April 16, 2004
Whole-blood cultures from renal-transplant patients stimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferation are related to P-glycoprotein expressionDave Singh, John Alexander, Andrew Owen, et al.
Respiratory Medicine|April 26, 2016
The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study)Dave Singh, Winfried Schröder-Babo, Géraldine Cohuet, et al.
Clinical Science (London, England : 1979)|August 3, 2013
CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patientsSeamus Grundy, Manminder Kaur, Jonathan Plumb, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 18, 2012
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cellsNadia Moretto, Serena Bertolini, Claudia Iadicicco, et al.
Pageof 51

Showing results (241-250 of 505) with videos related to

Sort By:
Pageof 51
Respiratory Medicine|April 7, 2020
Goals of COPD treatment: Focus on symptoms and exacerbationsClaus F Vogelmeier, Miguel Román-Rodríguez, Dave Singh, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 25, 2017
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromideDave Singh, Massimo Corradi, Monica Spinola, et al.
British Journal of Clinical Pharmacology|June 3, 2020
Therapeutic index of inhaled corticosteroids in asthma: A dose-response comparison on airway hyperresponsiveness and adrenal axis suppressionPeter Daley-Yates, Noushin Brealey, Sebin Thomas, et al.
International Immunopharmacology|October 29, 2011
Reduced glucocorticoid receptor expression and function in airway neutrophilsJonathan Plumb, Kate Gaffey, Binita Kane, et al.
Plos One|November 9, 2020
Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine studyHilary Siddall, Diana Quint, Hitesh Pandya, et al.
Therapeutic Advances in Respiratory Disease|August 25, 2021
Improvements in lung function with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler <i>versus</i> dual therapies in patients with COPD: a sub-study of the ETHOS trialKlaus F Rabe, Fernando J Martinez, Dave Singh, et al.
Transplantation|April 16, 2004
Whole-blood cultures from renal-transplant patients stimulated ex vivo show that the effects of cyclosporine on lymphocyte proliferation are related to P-glycoprotein expressionDave Singh, John Alexander, Andrew Owen, et al.
Respiratory Medicine|April 26, 2016
The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study)Dave Singh, Winfried Schröder-Babo, Géraldine Cohuet, et al.
Clinical Science (London, England : 1979)|August 3, 2013
CRAC channel inhibition produces greater anti-inflammatory effects than glucocorticoids in CD8 cells from COPD patientsSeamus Grundy, Manminder Kaur, Jonathan Plumb, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 18, 2012
Cigarette smoke and its component acrolein augment IL-8/CXCL8 mRNA stability via p38 MAPK/MK2 signaling in human pulmonary cellsNadia Moretto, Serena Bertolini, Claudia Iadicicco, et al.
Pageof 51